Elevance Health: CEO Buys As CareBridge Drives Strong Growth

Group 1 - Elevance Health, Inc. (NYSE: ELV) is rated as a Buy despite the severe impact on the healthcare plan providers industry, indicating a contrarian investment stance [1] - The industry has experienced deterioration in market prices, public opinion, and financial results, particularly affecting Elevance [1] - The investment approaches mentioned include GARP (Growth at a Reasonable Price), Value, and Growth, with a focus on insider buying and buybacks, as well as technical analysis tools like Elliott Wave and EMA crossovers [1]